Stay updated on Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Sign up to get notified when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page has been updated to version v2.16.5, and the previous version v2.16.4 has been removed from the content. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest in July 2025 has been deleted.
    Difference
    1%
    Check dated 2025-07-04T04:16:49.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    0.8%
    Check dated 2025-06-19T20:07:22.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.1%
    Check dated 2025-06-05T11:27:28.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated to announce a modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, allowing API users to provide input. Additionally, the previous version of the page has been removed, which included a section on Asian American Health.
    Difference
    2%
    Check dated 2025-05-29T06:14:39.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-04-30T18:44:49.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The web page has undergone significant changes, including the removal of detailed study objectives and inclusion/exclusion criteria for a clinical trial on Y90 radioembolization combined with nivolumab for hepatocellular carcinoma. Additionally, the principal investigator's name has been updated.
    Difference
    50%
    Check dated 2025-04-16T13:16:24.000Z thumbnail image

Stay in the know with updates to Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Y90-Radioembolization Plus Nivolumab in Asian HCC Clinical Trial page.